FDA Inspection 926021 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 3007686648

The FDA completed an inspection of Mary Bird Perkins Cancer Center on April 30, 2015 in Houma, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 30, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houma, LA (United States)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs